In their white paper, Meeting the Sophisticated Needs of Rare Disease Non-Commercial Pharmacy Management, RareMed Solutions explores the details of how non-commercial pharmacies play an enormous role in providing the proper therapies and programs to rare disease patients, while lessening …Read More →

  Celebrating the unstoppable entrepreneurs whose ambitions transform our world Ernst & Young LLP (EY US) announced today that Dr. Gordon J. Vanscoy, Chairman & CEO of RareMed Solutions, was named an Entrepreneur of The Year® 2020 East Central Award …Read More →

The following was publishes by the Pharmacy Times (2020-06-16 12:36:00) Author: Gannon Vanscoy, RareMed’s Director of Specialty Markets Specialty pharmacy hubs have become increasingly popular in recent years, offering a wide variety of services to pharmaceutical manufacturers. Although many hubs …Read More →

The following was published by the Pharmacy Times (2020-05-29 12:38:00) Author: Gannon Vanscoy, RareMed’s Director of Specialty Markets Technology is becoming increasingly important in the hub and patient services space supporting specialty pharmacy, as the effective use of innovative platforms …Read More →

The following was published by the Pharmacy Times (2020-04-23 15:48:00) Author: Gannon Vanscoy, RareMed’s Director of Specialty Markets As specialty pharmacy continues to evolve, new technology is becoming more vital to ensure the successful management of increasingly sophisticated products, patients …Read More →

Dr. Gordon Vanscoy, Chairman and CEO of PANTHERx Rare Pharmacy and RareMed Solutions, is honored to be headlining the April 2020 cover of Smart Business Magazine. The magazine features an interview that explores his approach to leadership, adaptability, and culture. …Read More →

In response to the COVID-19 pandemic, RareMed has been taking, and will continue to take, all measures to ensure that our patients and our partners will continue to receive the highest level of support while protecting our associates. RareMed has …Read More →

This year, the highly respected Journal of Managed Care & Specialty Pharmacy (JMCP) celebrates its 25th anniversary. To mark this milestone, they are publishing a series of landmark articles documenting the changes to the specialty pharmacy industry since the journal …Read More →

The following was published by the Pharmacy Times (2020-01-30 17:34:00) Author: Gannon Vanscoy, RareMed’s Director of Specialty Markets In the early 2000s, several products approved by the FDA were undergoing public scrutiny for serious and life-threatening adverse events (AEs). Vioxx, …Read More →

The end of the decade brought with it an exciting and critical trend for people living with rare diseases. Over the last eight years, the Center for Drug Evaluation and Research (CDER) approved more than twice as many orphan drugs …Read More →